Wegener's Granulomatosis [clinicaltrials_resource:141003d199791407fe7230313863b5d3]
Treatment of Wegener's Granulomatosis With Cyclophosphamide [clinicaltrials:NCT00001155]Steroids and Methotrexate to Treat Systemic Vasculitis [clinicaltrials:NCT00001256]Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides [clinicaltrials:NCT00001473]Diagnostic Effectiveness of Virtual Bronchoscopy [clinicaltrials:NCT00001515]Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis [clinicaltrials:NCT00001541]Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission Tomography [clinicaltrials:NCT00001759]Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis [clinicaltrials:NCT00001761]Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions [clinicaltrials:NCT00001764]Etanercept to Treat Wegener's Granulomatosis [clinicaltrials:NCT00001901]Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes [clinicaltrials:NCT00004567]Etanercept for Wegener's Granulomatosis [clinicaltrials:NCT00005007]Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases [clinicaltrials:NCT00006055]Daclizumab to Treat Wegener's Granulomatosis [clinicaltrials:NCT00040248]An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies [clinicaltrials:NCT00072592]clinicaltrials:NCT00103792clinicaltrials:NCT00104299RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides [clinicaltrials:NCT00307593]Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years [clinicaltrials:NCT00307671]Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides [clinicaltrials:NCT00430105]clinicaltrials:NCT00468208Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis [clinicaltrials:NCT00530075]clinicaltrials:NCT00747461Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides [clinicaltrials:NCT00751517]Anti-Cytokine Therapy for Vasculitis [clinicaltrials:NCT00753103]clinicaltrials:NCT01066208Study of One Protein Implicated in Wegener Disease [clinicaltrials:NCT01167491]clinicaltrials:NCT01408836clinicaltrials:NCT01988506clinicaltrials:NCT02108860Reproductive Health in Men and Women With Vasculitis [clinicaltrials:NCT02176070]
condition [clinicaltrials_vocabulary:condition]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Wegener's Granulomatosis [clinicaltrials_resource:141003d199791407fe7230313863b5d3]
Bio2RDF identifier
141003d199791407fe7230313863b5d3
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:141003d199791407fe7230313863b5d3
identifier
clinicaltrials_resource:141003d199791407fe7230313863b5d3
title
Wegener's Granulomatosis
@en
type
label
Wegener's Granulomatosis [clinicaltrials_resource:141003d199791407fe7230313863b5d3]
@en